Population-based Genetic Testing for Precision Prevention.

doi:10.1158/1940-6207.CAPR-20-0002

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Population-based Genetic Testing for Precision Prevention.

Cancer prevention research (Philadelphia, Pa.) - 1 Aug 2020

Evans Olivia, Manchanda Ranjit

Abstract excerpt

Global interest in genetic testing for cancer susceptibility genes (CSG) has surged with falling costs, increasing awareness, and celebrity endorsement. Current access to genetic testing is based on clinical criteria/risk model assessment which uses family history as a surrogate. However, this approach is fraught with inequality, massive underutilization, and misses 50% CSG carriers. This reflects huge missed...

Topics

Biomarkers, Tumor
Breast Neoplasms
Cost-Benefit Analysis
Counseling
DNA Mutational Analysis
Early Detection of Cancer
Female
Genetic Predisposition to Disease
Genetic Testing
Heterozygote
Humans
Jews
Mutation
Ovarian Neoplasms
Patient Education as Topic
Precision Medicine
Prevalence
Risk Assessment

Source

Open in PubMed

Identifiers

PMID: 32409595
DOI: 10.1158/1940-6207.CAPR-20-0002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics